BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4149365)

  • 1. Cardiovascular effects of tolamolol (UK-6558), a new beta-adrenoreceptor blocking drug, in pinealectomized hypertensive rats.
    Karppanen H; Lahovaara S; Mattila MJ
    Ann Med Exp Biol Fenn; 1973 Mar; 51(3):104-11. PubMed ID: 4149365
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE; Custy J; Steen RG; Newman WH
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina.
    Aronow WS; March H; Vangrow JS; Cassidy J; Kern JC; Khemka M; Vawter M; Pagano J
    Br Heart J; 1974 Nov; 36(11):1078-81. PubMed ID: 4155953
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of a new beta-adrenoceptor blocking compound, tolamolol, on haemo-dynamics and myocardial function in man.
    Hillis WS; Hutton I; Lawrie TD; Lorimer AR; Reid JM
    Br J Pharmacol; 1974 May; 51(1):15-9. PubMed ID: 4155334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
    Scriabine A; Torchiana ML; Stavorski JM; Ludden CT; Minsker DH; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR).
    Weiss L; Lundgren Y; Folkow B
    Acta Physiol Scand; 1974 Aug; 91(4):447-57. PubMed ID: 4154700
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on the action of talinolol (Cordanum, 02-115) on the coronary blood circulation].
    Modersohn D; Femmer K
    Pharmazie; 1975 Oct; 30(10):652-5. PubMed ID: 689
    [No Abstract]   [Full Text] [Related]  

  • 8. Distinct cardioselectivity of TR2732, a new beta adrenergic blocking agent.
    Reyes G; Ramírez T; Hong E
    Proc West Pharmacol Soc; 1991; 34():141-4. PubMed ID: 1686323
    [No Abstract]   [Full Text] [Related]  

  • 9. [Action of alpha- and beta-adrenergic blockaders on the effects of isadrin and noradrenaline in narcotized rats].
    Noravian OS; Abakian OM
    Zh Eksp Klin Med; 1978; 18(1):57-62. PubMed ID: 25545
    [No Abstract]   [Full Text] [Related]  

  • 10. Haemodynamic and coronary vascular responses after beta-adrenoceptor blockade in the anaesthetised dog: a comparison of tolamolol with practolol and propranolol.
    Adam KR; Boyles SM
    Eur J Pharmacol; 1974 Apr; 26(1):96-107. PubMed ID: 4151643
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of a new beta-blocking drug, DL 071-IT, on the myocardial contractile state in the waking dog; a comparison with 9 known beta blockaders].
    Marchetti G; Di Francesco GF; Baldoli E
    Boll Soc Ital Cardiol; 1979; 24(9):1039-43. PubMed ID: 45253
    [No Abstract]   [Full Text] [Related]  

  • 12. Central action of beta-adrenoreceptor blocking agents.
    Day MD; Roach AG
    Contrib Nephrol; 1977; 8():191-4. PubMed ID: 19201
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of tolamolol and bufuralol on the arterial blood pressure and plasma renin activity. Contribution to the study of beta-blocking agents action mechanisms (author's transl)].
    Rostan A
    Schweiz Rundsch Med Prax; 1978 Jan; 67(1):27-35. PubMed ID: 23523
    [No Abstract]   [Full Text] [Related]  

  • 14. Dose-effect relationship and safety of oral administration of penbutolol. A new beta adrenoceptor antagonist in normal subjects.
    Sharma PL; Sapru RP
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):98-101. PubMed ID: 25846
    [No Abstract]   [Full Text] [Related]  

  • 15. beta-adrenoreceptor blocking and antihypertensive activity of PP-24, a newly synthesized aryloxypropanolamine derivative.
    Nikam AP; Bodhankar SL; Piplani P; Bansal J; Thakurdesai PA
    J Pharm Pharmacol; 2008 Nov; 60(11):1501-6. PubMed ID: 18957171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of effects of beta-blocking drugs on blood glucose levels and insulin hypoglycaemia in rats.
    Baird JR; Carter AJ
    Eur J Pharmacol; 1974 Feb; 25(2):275-8. PubMed ID: 4154855
    [No Abstract]   [Full Text] [Related]  

  • 17. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
    Adam KR; Pullman LG; Scholfield PC
    Br J Pharmacol; 1973 Nov; 49(3):560-3. PubMed ID: 4149697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma renin activity after the use of a new beta-adrenergic blocking agent (I.C.I. 66,032).
    Aberg H
    Int J Clin Pharmacol; 1974 Mar; 9(2):98-100. PubMed ID: 4151244
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dose-response relationship of beta-adrenergic blocking agents].
    Seyberth H
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1663-5. PubMed ID: 4150008
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of propranolol on the blood pressure of normotensive and pinealectomized hypertensive rats.
    Karppanen H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(1):1-12. PubMed ID: 4273826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.